Stock Information

Cartesian Therapeutics Inc (RNAC)

Cartesian Therapeutics Inc logo
Ticker Symbol: RNAC
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $509.10 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.867
Revenue (TTM): $0.07 M
Dividend Yield: N/A%
ROE: -3215.82%

Latest News

Key Financials

Financial data not available